According to WiseGuy Reports, the Resin Capsule Market Outlook indicates that market revenue increased from USD 2,007.3 million in 2024 to USD 2,127.8 million in 2025. The industry is projected to reach USD 3,800 million by 2035, advancing at a CAGR of 6.0% during 2026–2035. Pharmaceutical industry expansion, growing consumption of dietary supplements, increasing interest in plant-based capsule formats, advances in production technologies, and greater awareness of sustainable materials are creating favorable conditions for future growth. Companies profiled include SABIC Innovative Plastics, Evonik Industries, Henkel, Mitsubishi Chemical, Dow, Huntsman, 3M, BASF, Arkema, Momentive, Albemarle, Ashland, Wacker Chemie, Solvay, and Sabic.

Market Overview

The demand for convenient dosage formats has made capsules an established component of pharmaceutical and consumer health manufacturing. Their applications extend across prescription medicines, over-the-counter products, health supplements, cosmetics, and selected food and beverage products.

Different capsule formats serve varying formulation needs. Gelatin and vegetable capsules address mainstream requirements, while enteric and hard capsules provide additional options for specialized applications.

Production methods also influence product characteristics and manufacturing efficiency. Wet and dry granulation, extrusion, and spray drying are used across different formulation and production environments.

Market Size

The industry generated USD 2,127.8 million in 2025 and is forecast to reach USD 3,800 million by 2035. Growth is expected to come from the increasing volume of pharmaceutical products and the continued expansion of the dietary supplement sector.

Prescription drugs remain a major application area because pharmaceutical manufacturers require reliable delivery formats for numerous formulations. Over-the-counter products similarly create steady demand through consumer healthcare markets.

Health supplements represent another expanding segment. Increasing availability of vitamins, minerals, botanical supplements, and wellness products through pharmacies, retailers, and digital channels is creating additional capsule demand.

Growth Opportunities

The shift toward plant-based products creates a promising opportunity for capsule manufacturers. Vegetable capsules can address demand from consumers and brands seeking alternatives to conventional gelatin-based formats.

Pharmaceutical development offers another avenue for expansion. New formulations and specialized drug delivery requirements can encourage demand for capsule materials with tailored performance characteristics.

E-commerce is expanding the market reach of nutraceutical and consumer healthcare products. Online platforms allow supplement brands to reach broader customer groups and support direct-to-consumer distribution.

Manufacturing technology is also creating opportunities. Improvements in production processes can support higher consistency, greater efficiency, and the development of capsule solutions for specialized applications.

Regional Analysis

North America is an important market due to its established pharmaceutical sector, developed nutraceutical industry, and high consumer participation in dietary supplements. The United States and Canada provide opportunities across prescription medicines, consumer healthcare, and wellness products.

Europe represents another significant region, supported by pharmaceutical manufacturing, established healthcare markets, and increasing interest in plant-based and sustainable products. Germany, the UK, France, Italy, Spain, and other European markets contribute to regional demand.

Asia Pacific offers considerable growth potential because of expanding pharmaceutical production, increasing healthcare consumption, and a growing middle-class population. China, India, Japan, South Korea, Malaysia, Thailand, and Indonesia represent important markets.

South America and the Middle East and Africa are expected to provide emerging opportunities as healthcare infrastructure, pharmaceutical consumption, and consumer health awareness continue to develop.

Recent Industry Developments

Plant-based capsule development is gaining attention as manufacturers seek to respond to changing consumer preferences. Vegetable-based formats can provide alternatives for nutraceutical and pharmaceutical products targeting specific consumer segments.

Manufacturing processes are also becoming more sophisticated. Advances in extrusion, spray drying, and other production techniques can help improve process efficiency and enable greater control over product characteristics.

The supplement industry's digital expansion is influencing capsule demand. Online retailers and direct-to-consumer brands are increasing the availability of capsule-based nutritional products.

Product innovation is also extending to capsule functionality. Manufacturers and pharmaceutical companies continue to explore formats that can meet different formulation and release requirements.

Market Challenges

Raw material availability and pricing can influence manufacturing economics. Fluctuations in material costs may affect production expenses and the final pricing of capsule products.

Regulatory requirements represent another challenge, particularly in pharmaceutical applications. Manufacturers must maintain consistent quality and meet applicable standards for materials and production processes.

Technical requirements can also complicate capsule development. Compatibility between capsule materials and formulations is important for maintaining product stability and performance.

Competition within the broader pharmaceutical and packaging supply chain can place pressure on manufacturers to maintain quality while controlling costs. Companies must continue investing in production capabilities and innovation to remain competitive.

Competitive Landscape

The competitive environment consists primarily of chemical companies, material manufacturers, and diversified suppliers supporting capsule-related production requirements. Market participants seek differentiation through material quality, technical capabilities, application expertise, and manufacturing reliability.

SABIC Innovative Plastics, Evonik Industries, Henkel, Mitsubishi Chemical, Dow, Huntsman, 3M, BASF, Arkema, Momentive, Albemarle, Ashland, Wacker Chemie, Solvay, and Sabic are among the key companies profiled.

Future competition is expected to center on plant-based material development, production efficiency, specialized capsule solutions, and support for pharmaceutical and nutraceutical applications. Companies able to align material innovation with the evolving requirements of drug and supplement manufacturers can strengthen their market positions as the industry advances toward 2035.